Frankfurt
20.08.25 | 08:12
0,062 Euro
+5,08 % +0,003
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,055 | 0,082 | 20.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Brown as program director | 1 | Stockwatch | ||
| Mo | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program | 1 | TheNewswire | ||
| Fr | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Launches Targeted Congenital Heart Defect Marketing Program, Setting Stage for Multi-Segment Growth | 1 | TheNewswire | ||
| 13.08. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Cardiac MRI Alternative Gets FDA Nod - Ventripoint CEO on U.S. and China Sales Plans | 271 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining... ► Artikel lesen | |
| 29.07. | Ventripoint Diagnostics Ltd (2): Ventripoint receives purchase order from Lishman | 1 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 28.07. | Ventripoint Diagnostics Ltd.: Lishman Global Places First Order for Ventripoint's VMS+ Technology | 1 | TheNewswire | ||
| 11.07. | Ventripoint Diagnostics Ltd (2): Ventripoint enters term sheet with Lishman for licence | 1 | Stockwatch | ||
| 11.07. | Ventripoint Diagnostics Ltd.: Ventripoint and Lishman Global Sign Non-binding Term Sheet Defining License for VMS+ Technology | 2 | TheNewswire | ||
| 11.07. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 564,473 shares for debt | 1 | Stockwatch | ||
| 30.06. | Ventripoint Diagnostics Ltd (2): Ventripoint to settle debenture interest with shares | 2 | Stockwatch | ||
| 30.06. | Ventripoint Diagnostics Ltd.: Ventripoint to Issue Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 18.06. | Ventripoint Diagnostics Ltd (2): Ventripoint hires Fournel for advisory services | 1 | Stockwatch | ||
| 17.06. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics grants options | 4 | Stockwatch | ||
| 17.06. | Ventripoint Diagnostics Ltd.: Ventripoint Partners with Fournel Advisory | 2 | TheNewswire | ||
| 17.06. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Option Grants and Reports Exercise of Options | 2 | TheNewswire | ||
| 28.05. | Ventripoint Diagnostics Ltd.: Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology | 1 | TheNewswire | ||
| 30.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Gall to business advisory board | 1 | Stockwatch | ||
| 30.04. | Ventripoint Diagnostics Ltd.: Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive | 1 | TheNewswire | ||
| 11.04. | Ventripoint Diagnostics Ltd (2): Ventripoint to hold shareholder teleconference April 15 | 1 | Stockwatch | ||
| 10.04. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 1 | TheNewswire |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,641 | +0,63 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update | FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required
Strong... ► Artikel lesen | |
| TANDEM DIABETES | 9,042 | -1,48 % | Tandem Diabetes To Pay Roche $36 Mln To Settle Patent Infringement Claim | SOUTH SAN FRANCISCO (dpa-AFX) - Tandem Diabetes Care, Inc. has agreed to pay Roche Holding $36 million over a five year period to settle a patent infringement claim.On May 21, Tandem Diabetes... ► Artikel lesen | |
| VERU | 3,550 | +9,57 % | Veru Announces Novel Modified-Release Oral Formulation for Enobosarm | ||
| MOLINA HEALTHCARE | 150,75 | +1,24 % | Molina Healthcare-Aktie mit leichten Kursgewinnen (142,1955 €) | Im Plus liegt zur Stunde der Anteilsschein von Molina Healthcare . Die Aktie notiert aktuell bei 166,40 US-Dollar. Ein Preisanstieg in Höhe von 6,77 US-Dollar erfreut derzeit die Aktionäre von Molina... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 2,140 | -2,01 % | Clover Health (CLOV) Achieves Profitability as Medicare Advantage Membership Surges | ||
| COGNETIVITY NEUROSCIENCES | 0,015 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY... ► Artikel lesen | |
| SHL TELEMEDICINE | - | - | SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer | ||
| SINTX TECHNOLOGIES | 3,270 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition | Company Reinforces Commercialization Focus and Strategic Direction SALT LAKE CITY, Utah, Aug. 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an advanced... ► Artikel lesen | |
| SOMNIGROUP INTERNATIONAL | 69,50 | -0,71 % | Somnigroup International Announces New Chief Executive Officer at Mattress Firm | DALLAS, Aug. 18, 2025 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI) announced today that Steve Rusing, currently serving as President of Mattress... ► Artikel lesen | |
| SEMLER SCIENTIFIC | 27,400 | +2,24 % | Semler Scientific, Inc.: Semler Scientific Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025 | CAMPBELL, Calif., Aug. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury... ► Artikel lesen | |
| SMILEDIRECTCLUB | - | - | Align Technology Settles Antitrust Lawsuit Over SmileDirectClub Deal for $31.75 Million | ||
| RELEVIUM | 0,013 | -100,00 % | Relevium Technologies Inc.: Relevium Technologies to be delisted from NEX | ||
| NEURONETICS | 2,900 | +1,58 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| FRESENIUS | 47,060 | +0,90 % | Fresenius-Aktie: Zu heiß gelaufen? | Die Fresenius-Aktie befindet sich weiterhin in einem starken Aufwärtstrend. Am Donnerstag eröffnet sie etwas leichter und steht aktuell bei 45,60 €. Hier stellt sich die Frage, ob sich ein Einstieg... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,270 | +0,60 % | FMC, Gerresheimer, HelloFresh, Lanxess, Puma, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen |
Das Unternehmen VENTRIPOINT DIAGNOSTICS LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,062 Euro und damit +5,08 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.